Aptevo Therapeutics Inc. Inventory Write-down
Aptevo Therapeutics Inc. (APVO) reported Inventory Write-down of $7.10 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2018-03-13
- Aptevo Therapeutics Inc. inventory write-down for the quarter ending 2016-09-30 was $2.90M.
- Aptevo Therapeutics Inc. inventory write-down for fiscal 2016 was $7.10M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 12 month |
|---|---|---|
| 2016-12-31 | $7.10M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $2.90M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |